Not applicableStudy completedNCT01140035What this trial is testingIntensive Insulin Therapy in Deceased DonorsWho this might be right forKidney Transplant University of California, San Francisco 200
Testing effectiveness (Phase 2)Looking for participantsNCT05027906What this trial is testingSafety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney TransplantWho this might be right forPrevention of Rejection in Kidney Transplant Eledon Pharmaceuticals 48
Not applicableActive Not RecruitingNCT07316829What this trial is testingTRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSWho this might be right forGraft RejectionKidney TransplantationLung Transplantation+6 more Fondazione IRCCS Policlinico San Matteo di Pavia 30
Post-approval studies (Phase 4)Study completedNCT00895583What this trial is testingStudy Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant RecipientsWho this might be right forGraft RejectionKidney TransplantRenal Allograft Recipients+1 more Pfizer 254
Not applicableStudy completedNCT01782586What this trial is testingValidation of Gene Expression Markers of Renal Allograft Functional DeclineWho this might be right forKidney Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 499
Large-scale testing (Phase 3)Study completedNCT00468117What this trial is testingEfficacy of Islet After Kidney TransplantationWho this might be right forType 1 Diabetes Mellitus National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT00261820What this trial is testingStudy Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsWho this might be right forGraft RejectionKidney FailureKidney Transplantation Wyeth is now a wholly owned subsidiary of Pfizer 160
Post-approval studies (Phase 4)Study completedNCT00713284What this trial is testingStudy Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving MyforticWho this might be right forRenal Transplantation California Pacific Medical Center Research Institute 29
Not applicableStudy completedNCT02057484What this trial is testingA 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney TransplantWho this might be right forLiver TransplantKidney Transplant Astellas Pharma Europe Ltd. 2,300
Testing effectiveness (Phase 2)Study completedNCT03663335What this trial is testingStudy of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant RecipientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals 418
Post-approval studies (Phase 4)Study completedNCT00905515What this trial is testingOptima: Optimizing Prograf Therapy in Maintenance Allografts IIWho this might be right forKidney Transplantation East Carolina University 63
Post-approval studies (Phase 4)Looking for participantsNCT04989491What this trial is testingEvaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney AllograftWho this might be right forEpstein-Barr Virus Infections University Hospital, Strasbourg, France 120
Post-approval studies (Phase 4)WithdrawnNCT01269684What this trial is testingImmediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant RecipientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00090194What this trial is testingImproving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%Who this might be right forKidney Failure, Chronic National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableEnded earlyNCT00235781What this trial is testingSingle Dose Thymoglobulin for Induction in Adult Renal Allograft RecipientsWho this might be right forKidney Transplantation Washington University School of Medicine 90
Not applicableStudy completedNCT00100516What this trial is testingDonor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney DonationWho this might be right forKidney Transplantation National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 40
Large-scale testing (Phase 3)Study completedNCT00195273What this trial is testingStudy Evaluating Sirolimus in Kidney Transplant RecipientsWho this might be right forGraft vs Host DiseaseKidney Transplantation Wyeth is now a wholly owned subsidiary of Pfizer 61
Not applicableEnrolling By InvitationNCT05058170What this trial is testingRenal Allograft Fibrosis StudyWho this might be right forRenal Allograft Fibrosis Icahn School of Medicine at Mount Sinai 162
Post-approval studies (Phase 4)UnknownNCT02036554What this trial is testingEvaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft RecipientsWho this might be right forKidney; Complications, Allograft Seoul St. Mary's Hospital 234
Early research (Phase 1)UnknownNCT01285375What this trial is testingSafety and Preliminary Efficacy of the Treatment of Kidney Allografts With Curcumin-containing Preservation SolutionWho this might be right forEnd Stage Renal Failure With Renal Transplant Helsinki University Central Hospital 20